Product | Sofosbuvir | Imatinib | Trastuzumab |
---|---|---|---|
Year of market launch | 2013 | 2001 | 1999 |
Year sales revenue surpassed R&D investment | 2015 | 2003 | 2000 |
Basic patent expiry date | 26/03/2028 | 25/03/2013 | 15/06/2012 |
SPC term | > 9 months | > 3 years 8 months | > 2 years 1 month |
SPC expiry date | 17/01/2029 | 21/12/2016 | 29/07/2014 |